{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:28:04Z","timestamp":1716942484714},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,28]]},"DOI":"10.7759\/cureus.61234","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T13:30:04Z","timestamp":1716903004000},"source":"Crossref","is-referenced-by-count":0,"title":["The Clinical Profile of Newly Diagnosed Acute Myeloid Leukemia at a Tertiary Care Center in South India: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Vandana G","family":"Hari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveenkumar","family":"Nallathambi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram","family":"Y","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthikeyan","family":"A","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shriganesh P","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.29309\/TPMJ\/2017.24.09.820","article-title":"Acute myeloid leukemia; demographic features and frequency of various subtypes in adult age group","volume":"24","author":"Naeem R","year":"2017","unstructured":"Naeem R, Naeem S, Sharif A, Rafique H, Naveed A. Acute myeloid leukemia; demographic features and frequency of various subtypes in adult age group. Prof Med J. 2017, 24:24-6. 10.29309\/TPMJ\/2017.24.09.820","journal-title":"Prof Med J"},{"key":"ref2","article-title":"Acute myeloid leukemia: pattern of clinical and hematological parameters in a tertiary care centre","volume":"16","author":"Khan MI","year":"2018","unstructured":"Khan MI. Acute myeloid leukemia: pattern of clinical and hematological parameters in a tertiary care centre. Int J Pathol. 2018, 16:2-4.","journal-title":"Int J Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22233","article-title":"Acute myeloid leukemia: epidemiology and etiology","volume":"107","author":"Deschler B","year":"2006","unstructured":"Deschler B, L\u00fcbbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer. 2006, 107:2099-107. 10.1002\/cncr.22233","journal-title":"Cancer"},{"key":"ref4","article-title":"Acute myeloid leukemia: a review","volume":"103","author":"Pelcovits A","year":"2020","unstructured":"Pelcovits A, Niroula R. Acute myeloid leukemia: a review. R I Med J (2013). 2020, 103:38-40.","journal-title":"R I Med J (2013)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2018.08.001","article-title":"Genetic and epigenetic determinants of AML pathogenesis","volume":"56","author":"Cai SF","year":"2019","unstructured":"Cai SF, Levine RL. Genetic and epigenetic determinants of AML pathogenesis. Semin Hematol. 2019, 56:84-9. 10.1053\/j.seminhematol.2018.08.001","journal-title":"Semin Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.50","article-title":"'Acute myeloid leukemia: a comprehensive review and 2016 update'","volume":"6","author":"De Kouchkovsky I","year":"2016","unstructured":"De Kouchkovsky I, Abdul-Hay M. 'Acute myeloid leukemia: a comprehensive review and 2016 update'. Blood Cancer J. 2016, 6:e441. 10.1038\/bcj.2016.50","journal-title":"Blood Cancer J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-012252","article-title":"Acute myeloid leukemia carrying cytoplasmic\/mutated nucleophosmin (NPMc+ AML): biologic and clinical features","volume":"109","author":"Falini B","year":"2007","unstructured":"Falini B, Nicoletti I, Martelli MF, Mecucci C. Acute myeloid leukemia carrying cytoplasmic\/mutated nucleophosmin (NPMc+ AML): biologic and clinical features. Blood. 2007, 109:874-85. 10.1182\/blood-2006-07-012252","journal-title":"Blood"},{"key":"ref8","article-title":"Classification of acute myeloid leukemias--a comparison of FAB and immunophenotyping","volume":"1","author":"Drexler HG","year":"1987","unstructured":"Drexler HG. Classification of acute myeloid leukemias--a comparison of FAB and immunophenotyping. Leukemia. 1987, 1:697-705.","journal-title":"Leukemia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2018.08.002","article-title":"The 2016 WHO classification of acute myeloid leukemia: what the practicing clinician needs to know","volume":"56","author":"Arber DA","year":"2019","unstructured":"Arber DA. The 2016 WHO classification of acute myeloid leukemia: what the practicing clinician needs to know. Semin Hematol. 2019, 56:90-5. 10.1053\/j.seminhematol.2018.08.002","journal-title":"Semin Hematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13406","article-title":"Acute myeloid leukaemia: challenges and real world data from India","volume":"170","author":"Philip C","year":"2015","unstructured":"Philip C, George B, Ganapule A, et al.. Acute myeloid leukaemia: challenges and real world data from India. Br J Haematol. 2015, 170:110-7. 10.1111\/bjh.13406","journal-title":"Br J Haematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner H","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, et al.. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022, 140:1345-77. 10.1182\/blood.2022016867","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/21556660.2018.1492925","article-title":"Impact of region of diagnosis, ethnicity, age, and gender on survival in acute myeloid leukemia (AML)","volume":"7","author":"Acharya UH","year":"2018","unstructured":"Acharya UH, Halpern AB, Wu QV, et al.. Impact of region of diagnosis, ethnicity, age, and gender on survival in acute myeloid leukemia (AML). J Drug Assess. 2018, 7:51-3. 10.1080\/21556660.2018.1492925","journal-title":"J Drug Assess"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1757233","article-title":"Clinico-hematological profile of acute leukemia cases in Bihar: a multiparameter study in a tertiary-care hospital","volume":"15","author":"Shuchismita S","year":"2023","unstructured":"Shuchismita S, Jamal I, Raman RB, Choudhary V. Clinico-hematological profile of acute leukemia cases in Bihar: a multiparameter study in a tertiary-care hospital. J Lab Physicians. 2023, 15:84-9. 10.1055\/s-0042-1757233","journal-title":"J Lab Physicians"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2015.10.020","article-title":"Sex disparity in childhood and young adult acute myeloid leukemia (AML) survival: evidence from US population data","volume":"39","author":"Hossain MJ","year":"2015","unstructured":"Hossain MJ, Xie L. Sex disparity in childhood and young adult acute myeloid leukemia (AML) survival: evidence from US population data. Cancer Epidemiol. 2015, 39:892-900. 10.1016\/j.canep.2015.10.020","journal-title":"Cancer Epidemiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-005-2301-3","article-title":"Occupational exposures and haematological malignancies: overview on human recent data","volume":"16","author":"Descatha A","year":"2005","unstructured":"Descatha A, Jenabian A, Conso F, Ameille J. Occupational exposures and haematological malignancies: overview on human recent data. Cancer Causes Control. 2005, 16:939-53. 10.1007\/s10552-005-2301-3","journal-title":"Cancer Causes Control"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.234","article-title":"Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study","volume":"29","author":"\u00d8stg\u00e5rd LS","year":"2015","unstructured":"\u00d8stg\u00e5rd LS, N\u00f8rgaard JM, Sengel\u00f8v H, et al.. Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study. Leukemia. 2015, 29:548-55. 10.1038\/leu.2014.234","journal-title":"Leukemia"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24464","article-title":"Epidemiology of childhood acute myeloid leukemia","volume":"60","author":"Puumala SE","year":"2013","unstructured":"Puumala SE, Ross JA, Aplenc R, Spector LG. Epidemiology of childhood acute myeloid leukemia. Pediatr Blood Cancer. 2013, 60:728-33. 10.1002\/pbc.24464","journal-title":"Pediatr Blood Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2014\/7854.4298","article-title":"Clinico-hematological study of acute myeloid leukemias","volume":"8","author":"Preethi CR","year":"2014","unstructured":"Preethi CR. Clinico-hematological study of acute myeloid leukemias. J Clin Diagn Res. 2014, 8:FC14-7. 10.7860\/JCDR\/2014\/7854.4298","journal-title":"J Clin Diagn Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S279736","article-title":"What does the economic burden of acute myeloid leukemia treatment look like for the next decade? An analysis of key findings, challenges and recommendations","volume":"5","author":"Forsythe A","year":"2021","unstructured":"Forsythe A, Sandman K. What does the economic burden of acute myeloid leukemia treatment look like for the next decade? An analysis of key findings, challenges and recommendations. J Blood Med. 2021, 5:245-55. 10.2147\/JBM.S279736","journal-title":"J Blood Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00726-1","article-title":"Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial","volume":"12","author":"Radhakrishnan V","year":"2022","unstructured":"Radhakrishnan V, Bakhshi S, Kayal S, et al.. Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial. Blood Cancer J. 2022, 12:131. 10.1038\/s41408-022-00726-1","journal-title":"Blood Cancer J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26395","article-title":"Prediction of early (4-week) mortality in acute myeloid leukemia with intensive chemotherapy","volume":"97","author":"Sasaki K","year":"2022","unstructured":"Sasaki K, Kadia T, Begna K, et al.. Prediction of early (4-week) mortality in acute myeloid leukemia with intensive chemotherapy. Am J Hematol. 2022, 97:68-78. 10.1002\/ajh.26395","journal-title":"Am J Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/256506-the-clinical-profile-of-newly-diagnosed-acute-myeloid-leukemia-at-a-tertiary-care-center-in-south-india-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T13:30:07Z","timestamp":1716903007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/256506-the-clinical-profile-of-newly-diagnosed-acute-myeloid-leukemia-at-a-tertiary-care-center-in-south-india-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.61234","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,28]]}}}